Costa Mark J 4

What Happened
Mark J. Costa, CEO and Board Chair of Eastman Chemical (EMN), received equity awards on February 24, 2026: 232,559 derivative option awards and 31,993 restricted stock units (RSUs). The reported acquisition price for both grants is $0.00 (these are compensation awards, not open‑market purchases), so no cash changed hands at grant. In total the awards equal 264,552 units that can become shares or give the right to buy shares over time.

Key Details

• Transaction date: February 24, 2026; filing date: February 26, 2026 (timely filing).
• Reported price: $0.00 (award/grant — no cash paid at grant).
• Awards granted: 232,559 option awards (derivative) and 31,993 restricted stock units (RSUs).
• Shares owned after transaction: not specified in the excerpt provided.
• Footnotes of note:
  • F1: Options vest in thirds — one‑third exercisable on Feb 24 in 2027, 2028 and 2029.
  • F2: Each RSU represents a contingent right to one share.
  • F3: RSUs vest and will be paid out in unrestricted shares on Feb 24, 2029, subject to continued employment.
• Filing status: appears timely (no late‑filing indicator shown).

Context
These are long‑term incentive awards intended for retention and alignment with shareholders, not an open‑market purchase or sale. The RSUs convert to shares only if Mr. Costa remains employed through the vest date (Feb 24, 2029). The options become exercisable over three years beginning Feb 24, 2027; the Form 4 shows the grant but does not indicate any immediate sale or exercise, so there is no immediate cash proceeds or change in public float from this filing.